Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Epilepsy D004827 35 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Birth Weight D001724 23 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Nasal Polyps D009298 26 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Ear Diseases D004427 7 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Agranulocytosis D000380 7 associated lipids
Shock D012769 11 associated lipids
Polycythemia Vera D011087 13 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Handa RK et al. Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney. 1991 Am. J. Physiol. pmid:1907104
Sirois MG and Edelman ER VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. 1997 Am. J. Physiol. pmid:9227554
Tomeo AC and Durán WN Resistance and exchange microvessels are modulated by different PAF receptors. 1991 Am. J. Physiol. pmid:1659229
Whittle BJ et al. Microvascular actions of platelet-activating factor on rat gastric mucosa and submucosa. 1986 Am. J. Physiol. pmid:3789144
Rizzo A et al. Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2. 1995 Am. J. Physiol. pmid:7771545
Olson NC et al. Pertussis toxin attenuates platelet-activating factor-induced pulmonary hemodynamic alterations in pigs. 1993 Am. J. Physiol. pmid:8460710
Widdicombe JH et al. Release of cyclooxygenase products from primary cultures of tracheal epithelia of dog and human. 1989 Am. J. Physiol. pmid:2514604
Munoz NM et al. Effects of PAF on isolated rat airways perfused with blood-free solution. 1991 Am. J. Physiol. pmid:2018147
Olson NC et al. Role of platelet-activating factor and eicosanoids during endotoxin-induced lung injury in pigs. 1990 Am. J. Physiol. pmid:2163217
Gaboury JP et al. Molecular mechanisms involved in superoxide-induced leukocyte-endothelial cell interactions in vivo. 1994 Am. J. Physiol. pmid:7908174
Sirén AL and Feuerstein G Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats. 1989 Am. J. Physiol. pmid:2546449
Wallace JL et al. Platelet-activating factor mediates gastric damage induced by hemorrhagic shock. 1990 Am. J. Physiol. pmid:2372058
Montrucchio G et al. Release of platelet-activating factor from ischemic-reperfused rabbit heart. 1989 Am. J. Physiol. pmid:2539755
Gozal D et al. Platelet-activating factor modulates cardiorespiratory responses in the conscious rat. 1998 Am. J. Physiol. pmid:9688699
Suzuki M et al. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. 1998 Am. J. Physiol. pmid:9458712
Gao Y et al. PAF induces relaxation of pulmonary arteries but contraction of pulmonary veins in the ferret. 1995 Am. J. Physiol. pmid:7653635
Conyers G et al. A factor in serum lowers resistance and opens tight junctions of MDCK cells. 1990 Am. J. Physiol. pmid:2221039
Badr KF et al. Glomerular responses to platelet-activating factor in the rat: role of thromboxane A2. 1989 Am. J. Physiol. pmid:2912165
Kvietys PR et al. Ethanol enhances leukocyte-endothelial cell interactions in mesenteric venules. 1990 Am. J. Physiol. pmid:2221068
Esplugues JV and Whittle BJ Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats. 1989 Am. J. Physiol. pmid:2919672
Kanwar S et al. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. 1994 Am. J. Physiol. pmid:8141295
Galens S et al. Assessment of agonist- and cell-mediated responses in airway microsections by computerized videomicrometry. 1995 Am. J. Physiol. pmid:7900832
Bonventre JV et al. PAF and PDGF increase cytosolic [Ca2+] and phospholipase activity in mesangial cells. 1988 Am. J. Physiol. pmid:3337246
Sun X et al. P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. 1997 Am. J. Physiol. pmid:9252509
Saito M et al. Association of granular exocytosis with Ca(2+)-activated K+ channels in human eosinophils. 1997 Am. J. Physiol. pmid:9252535
Hanglow AC et al. Effects of platelet-activating factor on ion transport in isolated rat jejunum. 1989 Am. J. Physiol. pmid:2597284
Bradley LM et al. Circulatory effects of PAF-acether in newborn piglets. 1989 Am. J. Physiol. pmid:2912183
Snyder F Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. 1990 Am. J. Physiol. pmid:2240190
Kubes P et al. Modulation of PAF-induced leukocyte adherence and increased microvascular permeability. 1990 Am. J. Physiol. pmid:2240225
Wallace JL Lipid mediators of inflammation in gastric ulcer. 1990 Am. J. Physiol. pmid:2405704
Huang Q et al. Neutrophil-dependent augmentation of PAF-induced vasoconstriction and albumin flux in coronary arterioles. 1998 Am. J. Physiol. pmid:9746460
Montrucchio G et al. Potential angiogenic role of platelet-activating factor in human breast cancer. 1998 Am. J. Pathol. pmid:9811351
O'Flaherty JT et al. Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents. 1981 Am. J. Pathol. pmid:6274199
Reznichenko A and Korstanje R The role of platelet-activating factor in mesangial pathophysiology. 2015 Am. J. Pathol. pmid:25655028
Rampart M and Williams TJ Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration. 1986 Am. J. Pathol. pmid:3524253
Lehr HA et al. In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation. 1995 Am. J. Pathol. pmid:7531948
Byrne SN et al. The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation. 2011 Am. J. Pathol. pmid:21703403
Montrucchio G et al. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. 1997 Am. J. Pathol. pmid:9250168
Zhou WG et al. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat. 1990 Am. J. Pathol. pmid:1701964
O'Flaherty JT et al. 1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. 1981 Am. J. Pathol. pmid:7223864
Boccellino M et al. Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility. 2005 Am. J. Pathol. pmid:15855650
Montrucchio G et al. Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart. 1990 Am. J. Pathol. pmid:2372044
Singh TP et al. Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice. 2011 Am. J. Pathol. pmid:21281802
Koyama S et al. Bradykinin stimulates type II alveolar cells to release neutrophil and monocyte chemotactic activity and inflammatory cytokines. 1998 Am. J. Pathol. pmid:9846978
Masubuchi T et al. Smoke extract stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activity. 1998 Am. J. Pathol. pmid:9846980
Stimler NP and O'Flaherty JT Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues. 1983 Am. J. Pathol. pmid:6624879
Wolf P et al. Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. 2006 Am. J. Pathol. pmid:16936256
Warren JS Relationship between interleukin-1 beta and platelet-activating factor in the pathogenesis of acute immune complex alveolitis in the rat. 1992 Am. J. Pathol. pmid:1519663
Flickinger BD and Olson MS Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells. 1999 Am. J. Pathol. pmid:10329588
O'Flaherty JT et al. Role of extracellular calcium and neutrophil degranulation responses to 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. 1981 Am. J. Pathol. pmid:6271016
Souza-Fiho MV et al. Involvement of nitric oxide in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. 1997 Am. J. Pathol. pmid:9006340
Valone FH and Goetzl EJ Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC). 1983 Am. J. Pathol. pmid:6624880
Bussolati B et al. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. 2000 Am. J. Pathol. pmid:11073830
Sun XM et al. Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor. 1990 Am. J. Pathol. pmid:2327475
Doi K et al. Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. 2006 Am. J. Pathol. pmid:16651609
McManus LM and Pinckard RN Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit. 1985 Am. J. Pathol. pmid:4050977
Montrucchio G et al. Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart. 1993 Am. J. Pathol. pmid:8434642
Hsueh W et al. Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis. 1986 Am. J. Pathol. pmid:3080895
Bussolati B et al. Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change. 1999 Am. J. Pathol. pmid:10027419
Elovitz MA et al. A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. 2003 Am. J. Pathol. pmid:14578208
Gonzalez-Crussi F and Hsueh W Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. 1983 Am. J. Pathol. pmid:6859226
Camussi G et al. Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor. 1983 Am. J. Pathol. pmid:6859232
Kispert S et al. Cigarette Smoke Regulates Calcium-Independent Phospholipase A Metabolic Pathways in Breast Cancer. 2017 Am. J. Pathol. pmid:28618256
Stimler NP et al. Anaphylactic actions of platelet-activating factor. 1981 Am. J. Pathol. pmid:6975043
Shaw JO and Henson PM The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets. 1980 Am. J. Pathol. pmid:6987890
Zhou W et al. Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat. 1992 Am. J. Pathol. pmid:1562055
Zhou W et al. Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation. 1993 Am. J. Pathol. pmid:8494049
Humphrey DM Inflammatory exudates in skin windows induced by 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine. 1990 Am. J. Pathol. pmid:2407127
Biancone L et al. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis. 1999 Am. J. Pathol. pmid:10550329
Emanuelli G et al. Experimental acute pancreatitis induced by platelet activating factor in rabbits. 1989 Am. J. Pathol. pmid:2464939
Wild MD and Roudebush WE Platelet-activating factor improves intrauterine insemination outcome. 2001 Am. J. Obstet. Gynecol. pmid:11349157
Hoffman DR et al. The role of platelet-activating factor in human fetal lung maturation. 1986 Am. J. Obstet. Gynecol. pmid:3728606
Tabor BL et al. Platelet-activating factor antagonists decrease lung protein leak in preterm ventilated rabbits. 1992 Am. J. Obstet. Gynecol. pmid:1530043
Narahara H and Johnston JM Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages. 1993 Am. J. Obstet. Gynecol. pmid:8372856
Claman P Platelet activating factor does not improve intrauterine insemination outcome. 2001 Am. J. Obstet. Gynecol. pmid:11717679
Benedetto C et al. Reduced serum inhibition of platelet-activating factor activity in preeclampsia. 1989 Am. J. Obstet. Gynecol. pmid:2912073
Morris C et al. Effects of platelet-activating factor on prostaglandin E2 production by intact fetal membranes. 1992 Am. J. Obstet. Gynecol. pmid:1566774
Maul H et al. Local application of platelet-activating factor induces cervical ripening accompanied by infiltration of polymorphonuclear leukocytes in rats. 2002 Am. J. Obstet. Gynecol. pmid:12388958
Zhu YP et al. The presence of platelet-activating factor binding sites in human myometrium and their role in uterine contraction. 1992 Am. J. Obstet. Gynecol. pmid:1314480
Rowland BL et al. Elevated circulating concentrations of platelet activating factor in preeclampsia. 2000 Am. J. Obstet. Gynecol. pmid:11035340
Matorras R and Pijoan JI The improvement in pregnancy rates with platelet-activating factor in intrauterine insemination was not demonstrated. 2002 Am. J. Obstet. Gynecol. pmid:11904634
Hoffman DR et al. Detection of platelet-activating factor in amniotic fluid of complicated pregnancies. 1990 Am. J. Obstet. Gynecol. pmid:2309839
Thaete LG and Neerhof MG Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat. 2006 Am. J. Obstet. Gynecol. pmid:16579936
Roudebush WE et al. Platelet activating factor enhances in vitro fertilization of rabbit oocytes. 1990 Am. J. Obstet. Gynecol. pmid:2240122
Minhas BS et al. Effects of platelet activating factor on mouse oocyte fertilization in vitro. 1989 Am. J. Obstet. Gynecol. pmid:2603931
Frostegård J et al. Antibodies against platelet-activating factor and platelet-activating factor-like lipids are raised in women with primary recurrent abortion. 2003 Am. J. Obstet. Gynecol. pmid:14520236
Silver RK et al. Anticardiolipin antibody-positive serum enhances endothelial cell platelet-activating factor production. 1991 Am. J. Obstet. Gynecol. pmid:1750472
Minhas BS Platelet-activating factor treatment of human spermatozoa enhances fertilization potential. 1993 Am. J. Obstet. Gynecol. pmid:8475981
Sueoka K et al. Platelet activating factor-induced early pregnancy factor activity from the perfused rabbit ovary and oviduct. 1988 Am. J. Obstet. Gynecol. pmid:3207134
Perico N and Remuzzi G Role of platelet-activating factor in renal immune injury and proteinuria. 1990 Am. J. Nephrol. pmid:2256482
Kees-Folts D and Diamond JR Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome. 1993 Am. J. Nephrol. pmid:8116689
Camussi G et al. Platelet-activating factor in renal diseases. 1989 Am. J. Nephrol. pmid:2646923
Ganong BR Roles of lipid turnover in transmembrane signal transduction. 1991 Am. J. Med. Sci. pmid:1661067
Muirhead EE et al. Biologic contrasts between medullipin I and vasoactive glyceryl compounds. 1989 Am. J. Med. Sci. pmid:2764021
Gaylord MS et al. Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia. 1996 Am. J. Med. Sci. pmid:8853062
Pitcock JA Morphometric studies of the renomedullary interstitial cells. 1988 Am. J. Med. Sci. pmid:3284348
Barnes PJ Inflammatory mechanisms and nocturnal asthma. 1988 Am. J. Med. pmid:3041827
Wasserman SI The mast cell and theophylline in asthma. 1985 Am. J. Med. pmid:3002176
Wright NR et al. Purulent Pericarditis and Abscessed Myocardium with Acute Myocardial Infarction. 2016 Am. J. Med. pmid:26524710
Tetta C et al. Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments. 1997 Am. J. Kidney Dis. pmid:9372980